Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 24, 2006Journal of Clinical OncologyOpen Access

Standard Chemotherapy Compared With High-Dose Chemoradiotherapy for Multiple Myeloma: Final Results of Phase III US Intergroup Trial S9321

View Full Paper
Ask AI
Bookmark
Share

Authors

Bart BarlogieBart BarlogieUniversity of Arkansas at Little RockRobert A. KyleRobert A. KyleDartmouth CollegeKenneth C. AndersonKenneth C. AndersonDana-Farber Cancer Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Barlogie et al. (2006) studied this question.

synapsesocial.com/papers/69c9f1a241c9e32f2f00da3dhttps://doi.org/10.1200/jco.2005.04.5807
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial2002 · 568 citations
  2. 2Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma2002 · 517 citations
  3. 3Progress in allogeneic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–98 at European Group for Blood and Marrow Transplantation centres2001 · 341 citations
  4. 4Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial1975 · 2,394 citations
  5. 5Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma2003 · 407 citations